Kristen M Little1, Allan W Taylor, Craig B Borkowf, Maria C B Mendoza, Margaret A Lampe, Paul J Weidle, Steven R Nesheim. 1. From the *Centers for Disease Control and Prevention (CDC), Washington, DC; National Center for Viral Hepatitis, HIV/AIDS, Sexually-Transmitted Disease and Tuberculosis Prevention (NCHHSTP), Division of HIV/AIDS Prevention (DHAP), Epidemiology Branch, Atlanta, GA; and †CDC, NCHHSTP, DHAP, Quantitative Sciences and Data Management Branch, Atlanta, GA.
Abstract
OBJECTIVES: Using published, nationally-representative estimates, we calculated the total number of perinatally HIV-exposed and HIV-infected infants born during 1978-2010, the number of perinatal HIV cases prevented by interventions designed for the prevention of mother-to-child transmission (PMTCT), and the number of infants exposed to antiretroviral (ARV) drugs during the prenatal and intrapartum periods. DESIGN: We calculated the number of infants exposed to ARV drugs since 1994, and the number of cases of mother-to-child HIV transmission prevented from 1994 to 2010 using published data. We generated confidence limits for our estimates by performing a simulation study. METHODS: Data were obtained from published, nationally-representative estimates from the Centers for Disease Control and Prevention. Model parameters included the annual numbers of HIV-infected pregnant women, the annual numbers of perinatally infected infants, the annual proportions of infants exposed to ARV drugs during the prenatal and intrapartum period and the estimated MTCT rate in the absence of preventive interventions. For the simulation study, model parameters were assigned distributions and we performed 1,000,000 repetitions. RESULTS: Between 1978 and 2010, an estimated 186,157 [95% confidence interval (CI): 185,312-187,003] HIV-exposed infants and approximately 21,003 (95% CI: 20,179-21,288) HIV-infected infants were born in the United States. Between 1994 and 2010, an estimated 124,342 (95% CI: 123,651-125,034) HIV-exposed infants were born in the US, and approximately 6083 (95% CI: 5931-6236) infants were perinatally infected with HIV. During this same period, about 100,207 (95% CI: 99,374-101,028) infants were prenatally exposed to ARV drugs. As a result of PMTCT interventions, an estimated 21,956 (95% CI: 20,191-23,759) MTCT HIV cases have been prevented in the United States since 1994. CONCLUSION: Although continued vigilance is needed to eliminate mother-to-child HIV transmission, PMTCT interventions have prevented nearly 22,000 cases of perinatal HIV transmission in the United States since 1994.
OBJECTIVES: Using published, nationally-representative estimates, we calculated the total number of perinatally HIV-exposed and HIV-infected infants born during 1978-2010, the number of perinatal HIV cases prevented by interventions designed for the prevention of mother-to-child transmission (PMTCT), and the number of infants exposed to antiretroviral (ARV) drugs during the prenatal and intrapartum periods. DESIGN: We calculated the number of infants exposed to ARV drugs since 1994, and the number of cases of mother-to-childHIV transmission prevented from 1994 to 2010 using published data. We generated confidence limits for our estimates by performing a simulation study. METHODS: Data were obtained from published, nationally-representative estimates from the Centers for Disease Control and Prevention. Model parameters included the annual numbers of HIV-infected pregnant women, the annual numbers of perinatally infected infants, the annual proportions of infants exposed to ARV drugs during the prenatal and intrapartum period and the estimated MTCT rate in the absence of preventive interventions. For the simulation study, model parameters were assigned distributions and we performed 1,000,000 repetitions. RESULTS: Between 1978 and 2010, an estimated 186,157 [95% confidence interval (CI): 185,312-187,003] HIV-exposed infants and approximately 21,003 (95% CI: 20,179-21,288) HIV-infectedinfants were born in the United States. Between 1994 and 2010, an estimated 124,342 (95% CI: 123,651-125,034) HIV-exposed infants were born in the US, and approximately 6083 (95% CI: 5931-6236) infants were perinatally infected with HIV. During this same period, about 100,207 (95% CI: 99,374-101,028) infants were prenatally exposed to ARV drugs. As a result of PMTCT interventions, an estimated 21,956 (95% CI: 20,191-23,759) MTCTHIV cases have been prevented in the United States since 1994. CONCLUSION: Although continued vigilance is needed to eliminate mother-to-childHIV transmission, PMTCT interventions have prevented nearly 22,000 cases of perinatal HIV transmission in the United States since 1994.
Authors: M L Lindegren; R H Byers; P Thomas; S F Davis; B Caldwell; M Rogers; M Gwinn; J W Ward; P L Fleming Journal: JAMA Date: 1999-08-11 Impact factor: 56.272
Authors: R S Sperling; D E Shapiro; R W Coombs; J A Todd; S A Herman; G D McSherry; M J O'Sullivan; R B Van Dyke; E Jimenez; C Rouzioux; P M Flynn; J L Sullivan Journal: N Engl J Med Date: 1996-11-28 Impact factor: 91.245
Authors: Ruth E Tuomala; David E Shapiro; Lynne M Mofenson; Yvonne Bryson; Mary Culnane; Michael D Hughes; M J O'Sullivan; Gwendolyn Scott; Alice M Stek; Diane Wara; Marc Bulterys Journal: N Engl J Med Date: 2002-06-13 Impact factor: 91.245
Authors: Wendy Yu; Denise L Jacobson; Paige L Williams; Kunjal Patel; Mitchell E Geffner; Russell B Van Dyke; Deborah Kacanek; Linda A DiMeglio; Jennifer Jao Journal: AIDS Date: 2022-03-15 Impact factor: 4.177
Authors: Steven R Nesheim; Jeffrey Wiener; Lauren F Fitz Harris; Margaret A Lampe; Paul J Weidle Journal: J Acquir Immune Defic Syndr Date: 2017-12-15 Impact factor: 3.731
Authors: Paige L Williams; Yanling Huo; Richard Rutstein; Rohan Hazra; Kathryn Rough; Russell B Van Dyke; Ellen G Chadwick Journal: AIDS Patient Care STDS Date: 2018-02 Impact factor: 5.078
Authors: Shu-Hong Lin; Youjin Wang; Stephen W Hartley; Danielle M Karyadi; Olivia W Lee; Bin Zhu; Weiyin Zhou; Derek W Brown; Erin Beilstein-Wedel; Rohan Hazra; Deborah Kacanek; Ellen G Chadwick; Carmen J Marsit; Miriam C Poirier; Sean S Brummel; Stephen J Chanock; Eric A Engels; Mitchell J Machiela Journal: AIDS Date: 2021-08-01 Impact factor: 4.632
Authors: Noah F Takah; Jeannine A Atem; Leopold N Aminde; Moffat Malisheni; Grant Murewenhema Journal: BMC Public Health Date: 2018-02-13 Impact factor: 3.295
Authors: Laura García-Otero; Marta López; Mariona Guitart-Mampel; Constanza Morén; Anna Goncé; Carol Esteve; Laura Salazar; Olga Gómez; Josep María Martínez; Berta Torres; Sergi César; Glòria Garrabou; Fàtima Crispi; Eduard Gratacós Journal: PLoS One Date: 2019-03-04 Impact factor: 3.240
Authors: Jodie Dionne-Odom; Michelle J Khan; Victoria C Jauk; Jeff Szychowski; Dustin M Long; Suzanne Wallace; Cherry Neely; Karen Fry; Jeanne Marrazzo; Marilyn Crain; Alan T N Tita Journal: Infect Dis Obstet Gynecol Date: 2019-04-01
Authors: Cassandra Oliver; Peter F Rebeiro; Mary J Hopkins; Beverly Byram; Lavenia Carpenter; Kate Clouse; Jessica L Castilho; William Rogers; Megan Turner; Sally S Bebawy; April C Pettit Journal: Open Forum Infect Dis Date: 2019-01-19 Impact factor: 3.835